Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Avid Bioservices, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
CDMO
Nasdaq
2836
www.avidbio.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Avid Bioservices, Inc.
Avid Bioservices Launches New Company Website Designed to Boost Company Brand Awareness and Enhance the Visitor Experience
- Feb 10th, 2025 1:05 pm
Avid Bioservices, Inc. Provides Notice of Fundamental Change and Make-Whole Fundamental Change to Holders of its Convertible Notes in Connection with Completed Merger
- Feb 5th, 2025 3:45 pm
Avid Bioservices poised for significant growth with new partners GHO Capital and Ampersand Capital Partners
- Feb 5th, 2025 2:55 pm
Avid Stockholders Approve Transaction with GHO and Ampersand
- Jan 30th, 2025 9:05 pm
Avid Reminds Stockholders to Vote Today FOR the Transaction with GHO and Ampersand
- Jan 22nd, 2025 9:05 pm
Avid Bioservices (CDMO) Started a Sale Process
- Jan 22nd, 2025 3:55 pm
Avid Recommends Stockholders Follow Recommendations of ISS and Glass Lewis and vote FOR the Transaction with GHO and Ampersand
- Jan 21st, 2025 1:00 pm
Avid Bioservices Files Investor Presentation Highlighting Value Maximizing Transaction with GHO and Ampersand
- Jan 8th, 2025 10:15 pm
Avid Bioservices Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by GHO and Ampersand
- Dec 30th, 2024 2:00 pm
Avid Bioservices Recommends Stockholders Vote FOR Value Maximizing Transaction
- Dec 18th, 2024 9:35 pm
Avid Bioservices: Fiscal Q2 Earnings Snapshot
- Dec 11th, 2024 10:03 am
Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2024
- Dec 10th, 2024 9:05 pm
Avid Bioservices, Inc. (CDMO): A Bull Case Theory
- Nov 17th, 2024 9:52 pm
Avid Bioservices to be Acquired in $1.1 Billion Deal
- Nov 8th, 2024 11:37 am
GHO and Ampersand Capital to acquire Avid Bioservices
- Nov 7th, 2024 11:59 am
Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction
- Nov 6th, 2024 11:04 pm
State Street Corp's Strategic Reduction in Avid Bioservices Inc Holdings
- Oct 17th, 2024 7:03 pm
Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference
- Sep 12th, 2024 8:05 pm
Avid Bioservices First Quarter 2025 Earnings: Misses Expectations
- Sep 10th, 2024 1:07 pm
Q1 2025 Avid Bioservices Inc Earnings Call
- Sep 10th, 2024 10:59 am
Scroll